Mean-avoiding Ornstein-Uhlenbeck process and unrestricted dividends
Mathematical Methods of Operations Research · 05.08.2026
DOI: 10.1007/s00186-026-00937-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mathematical Methods of Operations Research, online erschienen am 05.08.2026. Verfasst von Fabio Colpo und 1 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TU Wien.
Abstract (Originalsprache)
We consider an insurance company endowed with an initial capital and a surplus driven by a mean-avoiding Ornstein-Uhlenbeck (OU) process. The company’s target is to maximise the expected discounted unrestricted dividends. The parameters of the considered OU process are crucial for finding the optimal strategy. To solve the problem, we distinguish between three different cases. In the first case, the absolute value of the speed rate of the OU process is assumed to be strictly smaller than the constant discounting rate. Here, we are able to find both the optimal strategy – a bang-bang strategy with a constant barrier – and the value function. If the absolute value of the speed is equal to the discounting rate, we find an explicit expression for the value function and prove that the optimal strategy does not exist. In the last case, when the absolute value of the speed rate exceeds the discounting rate, the value function is infinite.
Förderung
- TU Wien
Zitieren
APA
Colpo, F., & Eisenberg, J. (2026). Mean-avoiding Ornstein-Uhlenbeck process and unrestricted dividends. Mathematical Methods of Operations Research. https://doi.org/10.1007/s00186-026-00937-3
Vancouver
Colpo F, Eisenberg J. Mean-avoiding Ornstein-Uhlenbeck process and unrestricted dividends. Mathematical Methods of Operations Research. 2026. doi:10.1007/s00186-026-00937-3
BibTeX
@article{Colpo2026,
author = {Colpo, Fabio and Eisenberg, Julia},
title = {Mean-avoiding Ornstein-Uhlenbeck process and unrestricted dividends},
journal = {Mathematical Methods of Operations Research},
year = {2026},
doi = {10.1007/s00186-026-00937-3}
}
EUVIMED